NCT01540253 2022-07-22
PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic
Roswell Park Cancer Institute
Phase 1 Completed
Clinical Trials
11 trialsNCT02146222 2019-11-18
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
University of Wisconsin, Madison
Phase 1 Completed
NCT00008125 2016-01-15
Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors
University of Pittsburgh
Phase 1 Completed
NCT00016185 2013-04-05
Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00084786 2013-01-17
Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00004913 2012-06-01
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Northwestern University
Phase 1 Completed
NCT00401180 2011-07-08
Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer
The Cleveland Clinic
Phase 1 Completed
NCT00415116 2011-07-08
Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors
The Cleveland Clinic
Phase 1 Completed
NCT00253344 2010-06-11
Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00004243 2010-01-13
Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
City of Hope Medical Center
Phase 1 Completed
NCT00004923 2009-08-25
Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors
Yale University
Phase 1/2 Completed